Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of SKI-O-703 Maintenance in Newly Diagnosed Immune Thrombocytopenia (ITP)
KCT0011512Phase 2Recruiting
- Sponsor
- Oscotec Inc.
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in immune thrombocytopenia (ITP) comparing SKI-O-703 maintenance with Placebo maintenance (2 arms). Started Jun 2026; status: recruiting.
02
Drugs
cevidoplenib
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on KCT0011512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011512.